These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 37545736)

  • 1. Sex differences in alpha-synucleinopathies: a systematic review.
    Raheel K; Deegan G; Di Giulio I; Cash D; Ilic K; Gnoni V; Chaudhuri KR; Drakatos P; Moran R; Rosenzweig I
    Front Neurol; 2023; 14():1204104. PubMed ID: 37545736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies.
    Pilotto A; Romagnolo A; Tuazon JA; Vizcarra JA; Marsili L; Zibetti M; Rosso M; Rodriguez-Porcel F; Borroni B; Rizzetti MC; Rossi C; Vizcarra-Escobar D; Molano JR; Lopiano L; Ceravolo R; Masellis M; Espay AJ; Padovani A; Merola A
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1257-1263. PubMed ID: 31142660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep stability in isolated rapid eye movement sleep behavior disorder, Parkinson's disease, and dementia with Lewy bodies.
    Bugalho P; Magriço M
    Acta Neurol Scand; 2022 Nov; 146(5):545-552. PubMed ID: 35974698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
    Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
    Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifelong constipation in Parkinson's disease and other clinically defined alpha-synucleinopathies: A population-based study in Southeast Minnesota.
    Camerucci E; Mullan AF; Bower JH; Bharucha AE; Turcano P; Stang CD; Benarroch EE; Boeve BF; Ahlskog JE; Savica R
    Parkinsonism Relat Disord; 2023 Feb; 107():105244. PubMed ID: 36630736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing multiple system atrophy at the prodromal stage.
    Xia C; Postuma RB
    Clin Auton Res; 2020 Jun; 30(3):197-205. PubMed ID: 32232688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
    Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
    Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysomnographic data in Dementia with Lewy Bodies: correlation with clinical symptoms and comparison with other α-synucleinopathies.
    Bugalho P; Salavisa M; Marto JP; Borbinha C; Alves L
    Sleep Med; 2019 Mar; 55():62-68. PubMed ID: 30772695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts.
    Somerville EN; Krohn L; Yu E; Rudakou U; Senkevich K; Ruskey JA; Asayesh F; Ahmad J; Spiegelman D; Dauvilliers Y; Arnulf I; Hu MTM; Montplaisir JY; Gagnon JF; Desautels A; Ibrahim A; Stefani A; Högl B; Gigli GL; Valente M; Janes F; Bernardini A; Dusek P; Sonka K; Kemlink D; Plazzi G; Antelmi E; Biscarini F; Mollenhauer B; Trenkwalder C; Sixel-Doring F; Figorilli M; Puligheddu M; De Cock VC; Oertel W; Janzen A; Ferini-Strambi L; Heibreder A; Monaca CC; Abril B; Dijkstra F; Viaene M; Boeve BF; Postuma RB; Rouleau GA; Gan-Or Z
    Neurobiol Aging; 2023 Jul; 127():94-98. PubMed ID: 37032242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha-Synucleinopathies.
    Stang CD; Mullan AF; Hajeb M; Camerucci E; Turcano P; Martin P; Mielke MM; Josephs KA; Bower JH; St Louis EK; Boeve BF; Savica R
    Ann Neurol; 2021 Feb; 89(2):293-303. PubMed ID: 33155696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy.
    Usenko TS; Senkevich KA; Bezrukova AI; Baydakova GV; Basharova KS; Zhuravlev AS; Gracheva EV; Kudrevatykh AV; Miliukhina IV; Krasakov IV; Khublarova LA; Fursova IV; Zakharov DV; Timofeeva AA; Irishina YA; Palchikova EI; Zalutskaya NM; Emelyanov AK; Zakharova EY; Pchelina SN
    Mol Neurobiol; 2022 Apr; 59(4):2277-2287. PubMed ID: 35066761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
    Singer W
    Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
    Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
    Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies.
    Pérez-Oliveira S; Álvarez I; Rosas I; Menendez-González M; Blázquez-Estrada M; Aguilar M; Corte D; Buongiorno M; Molina-Porcel L; Aldecoa I; Martí MJ; Sánchez-Juan P; Infante J; González-Aramburu I; García-González P; Rosende-Roca M; Boada M; Ruiz A; Periñán MT; Macías-García D; Muñoz-Delgado L; Gómez-Garre P; Mir P; Clarimón J; Lleo A; Alcolea D; De la Casa-Fages B; Duarte I; Álvarez V; Pastor P
    Mov Disord; 2022 Sep; 37(9):1841-1849. PubMed ID: 35852957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REM sleep behavior disorder (RBD).
    Hu MT
    Neurobiol Dis; 2020 Sep; 143():104996. PubMed ID: 32599063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid eye movement sleep behavior disorder and the link to alpha-synucleinopathies.
    Barone DA; Henchcliffe C
    Clin Neurophysiol; 2018 Aug; 129(8):1551-1564. PubMed ID: 29883833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.
    Schenck CH; Montplaisir JY; Frauscher B; Hogl B; Gagnon JF; Postuma R; Sonka K; Jennum P; Partinen M; Arnulf I; Cochen de Cock V; Dauvilliers Y; Luppi PH; Heidbreder A; Mayer G; Sixel-Döring F; Trenkwalder C; Unger M; Young P; Wing YK; Ferini-Strambi L; Ferri R; Plazzi G; Zucconi M; Inoue Y; Iranzo A; Santamaria J; Bassetti C; Möller JC; Boeve BF; Lai YY; Pavlova M; Saper C; Schmidt P; Siegel JM; Singer C; St Louis E; Videnovic A; Oertel W
    Sleep Med; 2013 Aug; 14(8):795-806. PubMed ID: 23886593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.